Data from the BANNER study show antiviral efficacy, safety, and tolerability of N6LS, supporting its continued study in phase IIb ViiV Healthcare, the global specialist HIV company majority owned
Estudio del subtitulado de las plataformas de comunicación discapnet.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from discapnet.es Daily Mail and Mail on Sunday newspapers.